(Q22305681)

English

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

1 reference

Europe PubMed Central

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (English)

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

0 references

1 reference

based on heuristic

inferred from title

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Siegfried Kasper

4

object named as

Siegfried Kasper

author given names

Siegfried

author last names

Kasper

1 reference

8 February 2023

Hans-Jürgen Möller

5

object named as

Hans-Jürgen Möller

author given names

Hans-Jürgen

author last names

Möller

1 reference

8 February 2023

Borwin Bandelow

1

object named as

Borwin Bandelow

author given names

Borwin

author last names

Bandelow

1 reference

8 February 2023

3

object named as

Eric Hollander

author given names

Eric

author last names

Hollander

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

author name string

Josef Zohar

2

author given names

Josef

author last names

Zohar

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

6

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

publication date

1 October 2002

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

3

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

171-199

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

4

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Current treatments of the anxiety disorders in adults

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

What treatments do patients with panic disorder and agoraphobia get?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind placebo-controlled pilot study of paroxetine for specific phobia.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The development of a Clinician-Administered PTSD Scale

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The association of alcoholism and anxiety

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind pilot trial of desipramine versus fluoxetine in panic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Does EMDR work? And if so, why?: a critical review of controlled outcome and dismantling research

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Economic costs of anxiety disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam and diazepam in the treatment of generalized anxiety

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Delivery outcome after the use of antidepressants in early pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Inositol treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Early coadministration of clonazepam with sertraline for panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neuroanatomical hypothesis of panic disorder, revised

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Comparison of buspirone and diazepam in generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Beneficial effect of nadolol on anxiety-induced disturbances of performance in musicians: a comparison with diazepam and placebo

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neurobiology of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Valproate treatment of panic disorder and lactate-induced panic attacks.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Panic attacks in the community. Social morbidity and health care utilization

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Citalopram in refractory obsessive-compulsive disorder: an open study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Psychological treatment of panic: work in progress on outcome, active ingredients, and follow-up.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Behaviour therapy for obsessive-compulsive disorder: a decade of progress

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Diazepam and Propranolol in Panic Disorder and Agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Citalopram for treatment-resistant obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of open-label nefazodone treatment in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Valproic acid and panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of obsessive-compulsive disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Long-term Therapeutic Use of Benzodiazepines

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Paroxetine efficacy in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Low dopamine D(2) receptor binding potential in social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Lorazepam vs. alprazolam in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of posttraumatic stress disorder: a review.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A controlled trial of phenelzine in posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Benzodiazepine dependency discontinuation: focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Psychological strategies for discontinuing benzodiazepine treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Advances in the neurobiology of obsessive-compulsive disorder. Implications for conceptualizing putative obsessive-compulsive and spectrum disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Group cognitive-behavioral treatment of panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Response of panic disorder to fixed doses of alprazolam or imipramine.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Interactive model of therapeutic response in panic disorder: moclobemide, a case in point

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The neurobiology of social phobia: from pharmacotherapy to brain imaging

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pharmacotherapy of Social Phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Suicidal ideation and suicide attempts in panic disorder and attacks.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pharmacologic treatment of depression during pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Long-term Therapeutic Use of Benzodiazepines

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Behavioral treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clinical Experience with Mirtazapine in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial1

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluvoxamine or Placebo in the Treatment of Panic Disorder and Relationship to Blood Concentrations of Fluvoxamine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine treatment of agoraphobic women. An eight-week controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressant and benzodiazepine for major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of negative crises (panic attacks)

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined pharmacological and behavioral treatment for agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of telephone-administered behavioral therapy for panic disorder with agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Brief psychotherapy for posttraumatic stress disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of alprazolam and behavior therapy in treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Social phobia: a comparison of behavior therapy and atenolol

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of bibliotherapy and group therapy in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of cognitive-behavioral treatment on quality of life in panic disorder patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Eye movement desensitization and reprocessing treatment for panic disorder: a controlled outcome and partial dismantling study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. AACAP

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Buspirone in the treatment of panic disorder: a controlled pilot comparison with clorazepate.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Moclobemide in social phobia: a controlled dose-response trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine in civilians with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term pharmacological treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Congenital malformations and maternal consumption of benzodiazepines: a case-control study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in social anxiety disorder: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year follow-up of exposure and imipramine treatment of agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Buspirone augmentation of fluoxetine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A crossover study of focused cognitive therapy for panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

ECT, research, and professional ambivalence

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Benzodiazepines in the Treatment of Anxiety

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pindolol on stress-related disturbances of musical performance: preliminary communication

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

[Rapid response of a disorder to the addition of lithium carbonate: panic resistant to tricyclic antidepressants]

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year follow-up of agoraphobics after exposure and imipramine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of citalopram in panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled trial of moclobemide in social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of pharmacologic treatment failure in panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

How psychiatrists can build new therapies for impotence

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine, Clomipramine, and Cognitive Therapy in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychotropic medications in pregnant women: treatment dilemmas.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.3109/15622970209150621

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22305681&oldid=2050103480"